ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Dermatologists, Otolaryngologists Differ on Skin Cancer Care

by Thomas R. Collins • November 1, 2013

  • Tweet
  • Email
Print-Friendly Version

You Might Also Like

  • Skin Cancer Care: Meeting Panelists Discuss Approaches
  • Advances in Head and Neck Skin Cancer Treatment
  • Experts Discuss Treatment Options for Skin Cancer Cases
  • SM14: Cases of Aggressive Skin Carcinoma Raise Treatment, Management Questions for Otolaryngologists
Explore This Issue
November 2013

Clear-cell squamous carcinoma.

VANCOUVER—The number of skin cancer cases in the U.S. is growing, and a huge number of those patients are treated with Mohs microsurgery, often performed by dermatologists. But a panel of head and neck surgery experts at the 2013 AAH-HNS Annual Meeting said that there are times when Mohs surgery might not be appropriate and that it’s a procedure that can come with down sides.

There has been a nearly 250 percent increase in procedures performed for skin cancer, paralleled by a rise in treatment of the disease by dermatologists, primarily through procedures performed in their offices, said Christine Gourin, MD, MPH, the session moderator and associate professor of otolaryngology-head and neck surgery at Johns Hopkins University in Baltimore. “Primarily, this treatment is Mohs,” she said. The microsurgery approach has been embraced because it spares healthy tissue while eradicating cancerous tissue, due to examination of the tissue during the procedure rather than afterward.

“The difficulty,” Dr. Gourin said, “is that dermatologists do not read the same literature that we do.” An example is literature acknowledging that the value of sentinel lymph node (SLN) biopsy is supported by evidence. “[Dermatologists] don’t see it as the standard of care,” she said.

Divide in Care Approach

Derrick Lin, MD, co-director of the Cranial Base Center at the Massachusetts Eye and Ear Infirmary in Boston, discussed the difference in approach between the head and neck surgery community and the dermatological community. “That’s always a tough question.… Most head and neck surgeons [will] say, ‘Well, Mohs is never indicated.’ You talk to a dermatologist, and they’ll say it’s indicated for everything. So, it’s always a hard divide between the two subspecialties.”

The dermatology literature says that resection without Mohs encompasses only 60 percent of margins, while Mohs encompasses the entire margin, accounting for its growth in popularity.

The degree to which the dermatology community has embraced Mohs surgery, he said, can be seen in a statement issued in 2012 by a consensus group of dermatologic surgeons. The group looked at 161 primary articles from the previous 71 years, case series of more than three and case reports. They tabulated the data and held four rounds of discussion.

The result is a report that concludes that Mohs is seen as “almost appropriate for everything,” Dr. Lin said. Both in and outside of the “H zone,” the area of the face that is considered at higher risk, the only situation deemed inappropriate for Mohs was primary or recurrent actinic keratosis with squamous cell carcinoma in situ.

Pages: 1 2 3 | Single Page

Filed Under: Features, Head and Neck, Practice Focus Tagged With: AAO-HNS annual meeting, Mohs surgery, sentinel lymph node biopsy, skin cancer, treatmentIssue: November 2013

You Might Also Like:

  • Skin Cancer Care: Meeting Panelists Discuss Approaches
  • Advances in Head and Neck Skin Cancer Treatment
  • Experts Discuss Treatment Options for Skin Cancer Cases
  • SM14: Cases of Aggressive Skin Carcinoma Raise Treatment, Management Questions for Otolaryngologists

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Weaning Patients Off of PPIs
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Podcasts Becoming More Popular Method of Education for Otolaryngologists
    • How to Embrace Optimism in the Midst of the COVID-19 Pandemic
    • Tips on How to Approach Conversations with Patients about the COVID-19 Vaccine
    • Steps You Should Take to Protect Your Voice and Hearing During Telemedicine Sessions
    • Routine Postoperative Adjunct Treatments Unnecessary for Idiopathic Cerebrospinal Fluid Leaks

Polls

Have you spoken with your patients about receiving the COVID-19 vaccine?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.